(ADP-ribose) polymerase 1 and AMP-activated protein kinase mediate progressive dopaminergic neuronal degeneration in a mouse model of Parkinson's disease

Cell Death and Disease

Volumn 4, Issue 11, 2013, Pages

  Kim, T W ^a   Cho, H M ^a   Choi, S Y ^a   Suguira, Y ^b   Hayasaka, T ^b   Setou, M ^b   Koh, H C ^c   Mi Hwang, E ^d   Park, J Y ^e   Kang, S J ^f   Kim, H S ^a   Kim, H ^a   Sun, W ^a  

^a Korea University College of Medicine   (South Korea)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Hanyang University   (South Korea)

^d Korea Institute of Science and Technology   (South Korea)

^e Gyeongsang National University School of Medicine   (South Korea)

^f Sejong University   (South Korea)

Author keywords

6 OHDA; AMPK; ATP; Parkinson's disease; PARP 1

Indexed keywords

ADENOSINE TRIPHOSPHATE; APOPTOSIS INDUCING FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; METFORMIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; OXIDOPAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATROPHY; CONTROLLED STUDY; DISEASE COURSE; DOPAMINERGIC NERVE CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; GENE DELETION; GENE TRANSLOCATION; MALE; MOUSE; MOUSE STRAIN; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; VIRUS INFECTION; WESTERN BLOTTING;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DOPAMINE; MALE; MASS SPECTROMETRY; MICE; MICE, KNOCKOUT; NEURONS; PARKINSON DISEASE; POLY(ADP-RIBOSE) POLYMERASES;

EID: 84889561434     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.447     Document Type: Article

References (60)

1. Dawson TM. New animal models for Parkinson's disease. Cell 2000; 101: 115-118
2. Turmel H, Hartmann A, Parain K, Douhou A, Srinivasan A, Agid Y, et al. Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Treated mice. Mov Disord 2001; 16: 185-189
3. Mladenovic A, Perovic M, Raicevic N, Kanazir S, Rakic L, Ruzdijic S. 6-Hydroxydopamine increases the level of TNFalpha and bax mRNA in the striatum and induces apoptosis of dopaminergic neurons in hemiparkinsonian rats. Brain Res 2004; 996: 237-245
4. Yang L, Calingasan NY, Wille EJ, Cormier K, Smith K, Ferrante RJ, et al. Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases. J Neurochem 2009; 109: 1427-1439
5. Ferreira IL, Resende R, Ferreiro E, Rego AC, Pereira CF. Multiple defects in energy metabolism in Alzheimer's disease. Curr Drug Targets 2010; 11: 1193-1206
6. Schapira AH, Gu M, Taanman JW, Tabrizi SJ, Seaton T, Cleeter M, et al. Mitochondria in the etiology and pathogenesis of Parkinson's disease. Ann Neurol 1998; 44: S89-S98
7. Jenner P, Olanow CW. The pathogenesis of cell death in Parkinson's disease. Neurology 2006; 66: S24-S36
8. Bloem BR, Irwin I, Buruma OJ, Haan J, Roos RA, Tetrud JW, et al. The MPTP model: Versatile contributions to the treatment of idiopathic Parkinson's disease. J Neurol Sci 1990; 97: 273-293
9. Hattori N, Tanaka M, Ozawa T, Mizuno Y. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease. Ann Neurol 1991; 30: 563-571
10. Schon EA, Przedborski S. Mitochondria: The next (neurode)generation. Neuron 2011; 70: 1033-1053
11. Mandir AS, Przedborski S, Jackson-Lewis V, Wang ZQ, Simbulan-Rosenthal CM, Smulson ME, et al. Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3, 6-Tetrahydropyridine (MPTP)-induced parkinsonism. Proc Natl Acad Sci USA 1999; 96: 5774-5779
12. Virag L, Szabo C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 2002; 54: 375-429
13. Virag L, Salzman AL, Szabo C. Poly(ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death. J Immunol 1998; 161: 3753-3759
14. Los M, Mozoluk M, Ferrari D, Stepczynska A, Stroh C, Renz A, et al. Activation and caspase-mediated inhibition of PARP: A molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol Biol Cell 2002; 13: 978-988
15. Yu SW, Andrabi SA, Wang H, Kim NS, Poirier GG, Dawson TM, et al. Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proc Natl Acad Sci USA 2006; 103: 18314-18319
16. Tapodi A, Debreceni B, Hanto K, Bognar Z, Wittmann I, Gallyas F Jr., et al. Pivotal role of Akt activation in mitochondrial protection and cell survival by poly(ADP-ribose)polymerase-1 inhibition in oxidative stress. J Biol Chem 2005; 280: 35767-35775
17. Wang Y, Kim NS, Haince JF, Kang HC, David KK, Andrabi SA, et al. Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos). Sci Signal 2011; 4: Ra20
18. Kim TW, Moon Y, Kim K, Lee JE, Koh HC, Rhyu IJ, et al. Dissociation of progressive dopaminergic neuronal death and behavioral impairments by bax deletion in a mouse model of Parkinson's diseases. PLoS ONE 2011; 6: E25346
19. Du L, Zhang X, Han YY, Burke NA, Kochanek PM, Watkins SC, et al. Intra-mitochondrial poly(ADP-ribosylation) contributes to NAD depletion and cell death induced by oxidative stress. J Biol Chem 2003; 278: 18426-18433
20. Woods A, Azzout-Marniche D, Foretz M, Stein SC, Lemarchand P, Ferre P, et al. Characterization of the role of AMP-Activated protein kinase in the regulation of glucoseactivated gene expression using constitutively active and dominant negative forms of the kinase. Mol Cell Biol 2000; 20: 6704-6711
21. Carling D, Mayer FV, Sanders MJ, Gamblin SJ. AMP-Activated protein kinase: Nature's energy sensor. Nat Chem Biol 2011; 7: 512-518
22. Ma TC, Buescher JL, Oatis B, Funk JA, Nash AJ, Carrier RL, et al. Metformin therapy in a transgenic mouse model of Huntington's disease. Neurosci Lett 2007; 411: 98-103
23. Chen Y, Zhou K, Wang R, Liu Y, Kwak YD, Ma T, et al. Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription. Proc Natl Acad Sci USA 2009; 106: 3907-3912
24. Kim HS, Hwang JT, Yun H, Chi SG, Lee SJ, Kang I, et al. Inhibition of AMP-Activated protein kinase sensitizes cancer cells to cisplatin-induced apoptosis via hyper-induction of p53. J Biol Chem 2008; 283: 3731-3742
25. Herceg Z, Wang ZQ. Failure of poly(ADP-ribose) polymerase cleavage by caspases leads to induction of necrosis and enhanced apoptosis. Mol Cell Biol 1999; 19: 5124-5133
26. Moubarak RS, Yuste VJ, Artus C, Bouharrour A, Greer PA, Menissier-de Murcia J, et al. Sequential activation of poly(ADP-ribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis. Mol Cell Biol 2007; 27: 4844-4862
27. Wang H, Shimoji M, Yu SW, Dawson TM, Dawson VL. Apoptosis inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson's disease. Ann N Y Acad Sci 2003; 991: 132-139
28. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002; 297: 259-263
29. Xu Y, Huang S, Liu ZG, Han J. Poly(ADP-ribose) polymerase-1 signaling to mitochondria in necrotic cell death requires RIP1/TRAF2-mediated JNK1 activation. J Biol Chem 2006; 281: 8788-8795
30. Mattson MP, Pedersen WA, Duan W, Culmsee C, Camandola S. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases. Ann N Y Acad Sci 1999; 893: 154-175
31. Wellstead P, Cloutier M. An energy systems approach to Parkinson's disease. Wiley Interdiscip Rev Syst Biol Med 2011; 3: 1-6
32. Sugiura Y, Taguchi R, Setou M. Visualization of spatiotemporal energy dynamics of hippocampal neurons by mass spectrometry during a kainate-induced seizure. PLoS One 2011; 6: E17952
33. Hardie DG. Minireview: The AMP-Activated protein kinase cascade: The key sensor of cellular energy status. Endocrinology 2003; 144: 5179-5183
34. Suter M, Riek U, Tuerk R, Schlattner U, Wallimann T, Neumann D. Dissecting the role of 5'-AMP for allosteric stimulation, activation, and deactivation of AMP-Activated protein kinase. J Biol Chem 2006; 281: 32207-32216
35. Poels J, Spasic MR, Callaerts P, Norga KK. Expanding roles for AMP-Activated protein kinase in neuronal survival and autophagy. Bioessays 2009; 31: 944-952
36. Ronnett GV, Ramamurthy S, Kleman AM, Landree LE, Aja S. AMPK in the brain: Its roles in energy balance and neuroprotection. J Neurochem 2009; 109: 17-23
37. Bolster DR, Crozier SJ, Kimball SR, Jefferson LS. AMP-Activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J Biol Chem 2002; 277: 23977-23980
38. Chan AY, Dyck Jr. Activation of AMP-Activated protein kinase (AMPK) inhibits protein synthesis: A potential strategy to prevent the development of cardiac hypertrophy. Can J Physiol Pharmacol 2005; 83: 24-28
39. Reiter AK, Bolster DR, Crozier SJ, Kimball SR, Jefferson LS. Repression of protein synthesis and mTOR signaling in rat liver mediated by the AMPK activator aminoimidazole carboxamide ribonucleoside. Am J Physiol Endocrinol Metab 2005; 288: E980-E988
40. Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008; 30: 214-226
41. Kim SR, Chen X, Oo TF, Kareva T, Yarygina O, Wang C, et al. Dopaminergic pathway reconstruction by Akt/Rheb-induced axon regeneration. Ann Neurol 2011; 70: 110-120
42. Kim SR, Kareva T, Yarygina O, Kholodilov N, Burke RE. AAV transduction of dopamine neurons with constitutively active Rheb protects from neurodegeneration and mediates axon regrowth. Mol Ther 2012; 20: 275-286
43. Meijer AJ, Codogno P. AMP-Activated protein kinase and autophagy. Autophagy 2007; 3: 238-240
44. Meley D, Bauvy C, Houben-Weerts JH, Dubbelhuis PF, Helmond MT, Codogno P, et al. AMP-Activated protein kinase and the regulation of autophagic proteolysis. J Biol Chem 2006; 281: 34870-34879
45. Viana R, Aguado C, Esteban I, Moreno D, Viollet B, Knecht E, et al. Role of AMP-Activated protein kinase in autophagy and proteasome function. Biochem Biophys Res Commun 2008; 369: 964-968
46. Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011; 13: 132-141
47. Narendra D, Tanaka A, Suen DF, Youle RJ. Parkin-induced mitophagy in the pathogenesis of Parkinson disease. Autophagy 2009; 5: 706-708
48. Vives-Bauza C, Zhou C, Huang Y, Cui M, de Vries RL, Kim J, et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci USA 2010; 107: 378-383
49. Concannon CG, Tuffy LP, Weisova P, Bonner HP, Davila D, Bonner C, et al. AMP kinase-mediated activation of the BH3-only protein Bim couples energy depletion to stress-induced apoptosis. J Cell Biol 2010; 189: 83-94
50. Du H, Wolf J, Schafer B, Moldoveanu T, Chipuk JE, Kuwana T. BH3 domains other than Bim and Bid can directly activate Bax/Bak. J Biol Chem 2011; 286: 491-501
51. Chou SY, Lee YC, Chen HM, Chiang MC, Lai HL, Chang HH, et al. CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model. J Neurochem 2005; 93: 310-320
52. McCullough LD, Zeng Z, Li H, Landree LE, McFadden J, Ronnett GV. Pharmacological inhibition of AMP-Activated protein kinase provides neuroprotection in stroke. J Biol Chem 2005; 280: 20493-20502
53. Lopez-Lopez C, Dietrich MO, Metzger F, Loetscher H, Torres-Aleman I. Disturbed cross talk between insulin-like growth factor I and AMP-Activated protein kinase as a possible cause of vascular dysfunction in the amyloid precursor protein/presenilin 2 mouse model of Alzheimer's disease. J Neurosci 2007; 27: 824-831
54. Ju TC, Chen HM, Lin JT, Chang CP, Chang WC, Kang JJ, et al. Nuclear translocation of AMPK-Alpha1 potentiates striatal neurodegeneration in Huntington's disease. J Cell Biol 2011; 194: 209-227
55. Mairet-Coello G, Courchet J, Pieraut S, Courchet V, Maximov A, Polleux F. The CAMKK2-AMPK Kinase Pathway Mediates the Synaptotoxic Effects of Abeta Oligomers through Tau Phosphorylation. Neuron 2013; 78: 94-108
56. Hagberg H, Wilson MA, Matsushita H, Zhu C, Lange M, Gustavsson M, et al. PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury. J Neurochem 2004; 90: 1068-1075
57. Sugiura Y, Shimma S, Setou M. Thin Sectioning Improves the Peak Intensity and Signal-To-Noise Ratio in Direct Tissue Mass Spectrometry. J Mass Spectrom Soc Jpn 2006; 54: 4
58. Schwartz SA, Reyzer ML, Caprioli RM. Direct tissue analysis using matrix-Assisted laser desorption/ionization mass spectrometry: Practical aspects of sample preparation. J Mass Spectrom 2003; 38: 699-708
59. Iancu R, Mohapel P, Brundin P, Paul G. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice. Behav Brain Res 2005; 162: 1-10
60. Mori A, Ohashi S, Nakai M, Moriizumi T, Mitsumoto Y. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-Treated C57BL/6 mice. Neurosci Res 2005; 51: 265-274